Accreditation and Rankings

UCLA places among the nation’s best

An overview of what makes UCLA, and the DGSOM, unique.

The Geffen Hall building with the emphasis on the blue sky all around it.

UCLA, and the David Geffen School of Medicine at UCLA, performs well in all national and international rankings of public and private universities, including the most widely known list published by U.S. News & World Report. Here you'll be in good company with leaders across our mission areas working to impact the world for good.

 

 

National Rankings

#3

UCLA Health, Nationally Ranked Health System, 2021

#1

UCLA, Nationally Ranked Public University, 2021

$559M

DGSOM, National Institutes of Health Research Funding, 2022

#14

Most diverse medical school, U.S. News & World Report, 2022

#13

Best medical schools, Primary Care, U.S. News & World Report, 2022

#19

Best medical schools, Research, U.S. News & World Report, 2022

 

 

Educational Range and Quality of Experience

6

Partner/concurrent degree programs for medical students

99

ACGME accredited speciality and subspecialty programs

17

Distinct fields of PhD training in the biosciences

284

On average, there are 284 sunny days per year in Los Angeles

 

 

Excellence in Faculty and Mentorship

35

American Society for Clinical Investigation Members

35

National Academy of Medicine Members

20

National Academy of Sciences Members

8

UCLA-wide Nobel Laureates

 

 

LCME Accreditation

The David Geffen School of Medicine at UCLA (DGSOM) is accredited by the Liaison Committee for Medical Education (LCME), the accrediting agency serving medical schools in United States and Canada. Accreditation by the LCME establishes eligibility for selected federal grants and programs, including Title VII funding administered by the U.S. Public Health Service. Additionally, graduate of LCME-accredited schools are eligible for residency programs accredited by the Accreditation Council for Graduate Medical Education (ACGME). DGSOM was first accredited by the LCME in 1951.

In February 2021, DGSOM participated in a site visit to seek our eight-year reaccreditation from the LCME. This is a peer-reviewed process of quality assurance that determines whether an institution’s program and medical school meet nationally established standards, outlined in the Functions and Structure of a Medical School. The almost two-year self-study process that followed included our entire educational community — faculty, residents, staff, and students — whom provided valuable reflection on our strengths and important feedback on how we can continue to improve as a medical school.

The February 2021 site visit consisted of submitting a survey package containing the following:

  • Data Collection Instrument (DCI)
  • Institutional Self-Study
  • Independent Student Analysis

The survey package is available to review in Box. The outcome to the 2021 reaccreditation visit will be announced Fall 2021. For more information about the LCME, please visit https://lcme.org.

Review Survey Package